1. Home
  2. ALNY vs LULU Comparison

ALNY vs LULU Comparison

Compare ALNY & LULU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALNY
  • LULU
  • Stock Information
  • Founded
  • ALNY 2002
  • LULU 1998
  • Country
  • ALNY United States
  • LULU Canada
  • Employees
  • ALNY N/A
  • LULU N/A
  • Industry
  • ALNY Biotechnology: Pharmaceutical Preparations
  • LULU Apparel
  • Sector
  • ALNY Health Care
  • LULU Consumer Discretionary
  • Exchange
  • ALNY Nasdaq
  • LULU Nasdaq
  • Market Cap
  • ALNY 38.1B
  • LULU 45.5B
  • IPO Year
  • ALNY 2004
  • LULU 2007
  • Fundamental
  • Price
  • ALNY $303.77
  • LULU $334.91
  • Analyst Decision
  • ALNY Strong Buy
  • LULU Buy
  • Analyst Count
  • ALNY 25
  • LULU 26
  • Target Price
  • ALNY $324.54
  • LULU $359.13
  • AVG Volume (30 Days)
  • ALNY 1.1M
  • LULU 1.8M
  • Earning Date
  • ALNY 07-31-2025
  • LULU 06-05-2025
  • Dividend Yield
  • ALNY N/A
  • LULU N/A
  • EPS Growth
  • ALNY N/A
  • LULU 20.00
  • EPS
  • ALNY N/A
  • LULU 14.64
  • Revenue
  • ALNY $2,348,099,000.00
  • LULU $10,588,126,000.00
  • Revenue This Year
  • ALNY $30.28
  • LULU $8.52
  • Revenue Next Year
  • ALNY $30.25
  • LULU $7.31
  • P/E Ratio
  • ALNY N/A
  • LULU $22.88
  • Revenue Growth
  • ALNY 17.21
  • LULU 10.07
  • 52 Week Low
  • ALNY $147.25
  • LULU $226.01
  • 52 Week High
  • ALNY $307.85
  • LULU $423.32
  • Technical
  • Relative Strength Index (RSI)
  • ALNY 66.72
  • LULU 67.55
  • Support Level
  • ALNY $284.73
  • LULU $311.32
  • Resistance Level
  • ALNY $295.44
  • LULU $322.94
  • Average True Range (ATR)
  • ALNY 9.24
  • LULU 8.32
  • MACD
  • ALNY 1.41
  • LULU 1.07
  • Stochastic Oscillator
  • ALNY 91.14
  • LULU 82.47

About ALNY Alnylam Pharmaceuticals Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.

About LULU lululemon athletica inc.

Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 700 company-owned stores in about 20 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.

Share on Social Networks: